Skip to content

Does Triamcinolone acetonide injection in suprachoroidal space of eye during cataract operation improve vision in cases complicated by non infectious uveitis (an inflammatory disease of eye)

A comparative study of surgical outcome of uveitic cataract with and without injection suprachoroidal triamcinolone acetonide - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103032
Enrollment
50
Registered
2026-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H200- Acute and subacute iridocyclitis

Interventions

Intervention1: Suprachoroidal triamcinolone acetonide injection: GroupA-phacoemulsification with injection suprachoroidal triamcinolone acetonide Control Intervention1: Phacoemulsification only: Gro

Sponsors

GSVM Medical College Kanpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient diagnosed with uveitic cataract 2.patient who give informed consent for examination,medical treatment and surgery 3.patients who are mentally and physically fit to participate in study and to further follow up for 3 months

Exclusion criteria

Exclusion criteria: 1.patient not willing to participate or ready for follow up 2.patients having history of glaucoma,steroid induced ocular HTN 3.patient diagnosed of any other retinal or vitreous pathology 4.patients having uncontrolled diabetes 5.patients having any systemic illness or any debiliating disease

Design outcomes

Primary

MeasureTime frame
Improvement in visionTimepoint: day 0,3,7 2 weeks,4weeks 2 months,3 month

Secondary

MeasureTime frame
Improvement in best corrected visual acuity(BCVA) Timepoint: day 0,3,7 2 weeks,4weeks 2 months,3 month

Countries

India

Contacts

Public ContactDr Priya Tripathi

GSVM Medical College Kanpur

tripathipriya0917@gmail.com8318068633

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026